loadpatents
name:-0.012862920761108
name:-0.0057342052459717
name:-0.00039196014404297
Blackler; Paul David James Patent Filings

Blackler; Paul David James

Patent Applications and Registrations

Patent applications and USPTO patent grants for Blackler; Paul David James.The latest application filed is for "5-[4-[2-(n-methyl-n-(2-pyridyl)amino)ethoxy]benzyl]thiazolidine-2,4-dione, maleic acid salt, hydrate as pharmaceutical".

Company Profile
0.6.10
  • Blackler; Paul David James - Cadiz ES
  • BLACKLER; Paul David James - Tonbridge GB
  • Blackler, Paul David James - TUNBRIDGE GB
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Thiazolidinedione derivative and its use as antidiabetic
Grant 7,358,366 - Blackler , et al. April 15, 2
2008-04-15
5-[4-[2-(n-methyl-n-(2-pyridyl)amino)ethoxy]benzyl]thiazolidine-2,4-dione, Maleic Acid Salt, Hydrate As Pharmaceutical
App 20070203200 - Sasse; Michael John ;   et al.
2007-08-30
5-[4-[2-(N-methyl-N-(2-pyridyl)amino)ethoxy]benzyl]thiazolidine-2, 4-dione, maleic acid salt, hydrate as pharmaceutical
Grant 7,230,109 - Sasse , et al. June 12, 2
2007-06-12
Thiazolidinedione Derivative And Its Use As Antidiabetic
App 20060247279 - Blackler; Paul David James ;   et al.
2006-11-02
Hydrate of 5-[4-[2-(N-methyl-N-(2-pyridyl)amino)ethoxy]benzyl]thiazolidine- -2, 4-dione maleic acid salt
App 20060189659 - Sasse; Michael John ;   et al.
2006-08-24
Hydrate of 5-[4-[2-(N-methyl-N-(2-pyridil)amino)ethoxy]benzyl]thiazolidine- -2,4-dione maleic acid salt
Grant 7,045,633 - Sasse , et al. May 16, 2
2006-05-16
Polymorph of 5-[4-[2-(N-methyl-N-(2-pyridyl)amino)ethoxy]benzyl]thiazolidi- ne-2, 4-dione, maleic acid salt
App 20050080114 - Blackler, Paul David James ;   et al.
2005-04-14
Thiazolidinedione derivative and its use as antidiabetic
App 20040248945 - Blackler, Paul David James ;   et al.
2004-12-09
Thiazolidinedione derivative and its use as antidiabetic
Grant 6,815,457 - Blackler , et al. November 9, 2
2004-11-09
5-[4-[2-(N-methyl-N-(2-pyridyl)amino)ethoxy]benzyl]thiazolidine-2, 4-dione, maleic acid salt, hydrate as pharmaceutical
App 20040214865 - Sasse, Michael John ;   et al.
2004-10-28
Polymorph of 5-[4-[2-(n-methyl-n(2-pyridyl)amino)ethoxy]benzyl]-thiazolidine-2,4-dione, maleic acid salt
Grant 6,806,280 - Blackler , et al. October 19, 2
2004-10-19
Hydrate of 5-[4-[2-(N-methyl-N-(2-pyridil)amino)ethoxy]benzyl]thiazolidine- -2,4-dione maleic acid salt
App 20040097553 - Sasse, Michael John ;   et al.
2004-05-20
Pharmaceutical compositions of a thiazolidinedione derivative and their use as antidiabetics
App 20040092555 - Blackler, Paul David James ;   et al.
2004-05-13
Hydrate of 5-[4-[2-(N-methyl-N-(2-pyridil)amino)ethoxy]benzyl]thiazolidine-2,4-dione maleic acid salt
Grant 6,664,278 - Sasse , et al. December 16, 2
2003-12-16
5-[4-[2-(N-methyl-N-(2-pyridyl)amino)ethoxy]benzyl]thiazolidine-2,4-dione, maleic acid salt, hydrate as pharmaceutical
App 20030120078 - Sasse, Michael John ;   et al.
2003-06-26
Hydrate of 5-[4-[2-(N-methyl-N-(2-pyridil)amino)ethoxy]benzyl]thiazolidine- -2,4-dione maleic acid salt
App 20020099081 - Sasse, Michael John ;   et al.
2002-07-25

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed